- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05792436
Continuous Versus 1-min Oscillometric Arterial BP Monitoring
Continuous Invasive Versus 1-min Interval Oscillometric Arterial Pressure Monitoring and Hypotension During Induction of Anesthesia: a Bicenter, Randomized, Noninferiority Trial
Hypotension is common during surgery and about one-third of hypotension occur during the period from anesthesia induction to skin incision. Therefore, monitoring blood pressure during this period is crucial.
Two methods are used for measuring blood pressure during surgery: the intermittent measurement method (oscillometric method) and the continuous measurement method (arterial catheterization method). The latter is frequently used in surgical patients who require meticulous hemodynamic management, although there is no clearly defined indication for its use. Despite the benefits of arterial catheterization, it is often delayed after induction of general anesthesia, and blood pressure is monitored intermittently using the oscillometric method.
A recent study showed that continuous arterial pressure monitoring using arterial catheterization method during the induction of general anesthesia reduced hypotension significantly compared to 2.5-min interval intermittent arterial pressure monitoring using oscillometric method. The study was conducted on patients scheduled for continuous arterial pressure monitoring during surgery and the group with continuous arterial pressure monitoring showed significantly lower incidence of hypotension during the first 15 minutes of anesthesia induction.
However, measuring blood pressure using the oscillometric method at 1-min interval, rather than 2.5-min interval, may not be significantly inferior to continuous monitoring via arterial catheterization in terms of hypotension occurrence. This study aims to compare hypotension incidence between arterial catheterization method and oscillometric method with 1-min interval during induction of anesthesia in non-cardiac surgery patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karam Nam, MD
- Phone Number: 82-2-2072-0643
- Email: karamnam@gmail.com
Study Contact Backup
- Name: Jae-Woo Ju, MD
- Phone Number: 82-2-2072-2467
- Email: jujw701@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Recruiting
- Seoul National University Hospital
-
Contact:
- Karam Nam, M.D.
- Phone Number: 82-02-2072-0643
- Email: karamnam@gmail.com
-
Contact:
- Jae-Woo Ju, M.D.
- Phone Number: 82-02-2072-2469
- Email: jujw701@gmail.com
-
Seoul, Korea, Republic of
- Not yet recruiting
- Korea University Guro Hospital
-
Contact:
- Hye-Bin Kim, M.D.
- Email: aneshbkim@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aged 19 or older undergoing scheduled non-cardiac surgery with general anesthesia and continuous invasive arterial blood pressure monitoring via the radial artery
Exclusion Criteria:
- Arterial access is clinically necessary before induction of anesthesia (e.g., moderate or higher degree of aortic stenosis, moderate or higher degree of heart failure, coronary artery disease requiring revascularization, intracranial aneurysm with a significant risk of rupture, etc.)
- Emergency surgery
- American Society of Anesthesiologists (ASA) physical status 5 or 6
- Arterial access is required in a different artery other than the radial artery (e.g., the femoral artery)
- Electrocardiogram other than sinus rhythm
- Refusal to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1-min interval oscillometric method
1-min interval blood pressure monitoring using oscillometric method during induction of anesthesia
|
Before induction of anesthesia, 20-gauge catheter is inserted to radial artery after local anesthesia with lidocaine, and continuous blood pressure monitoring is started. Anesthesia is induced using propofol, opioids (fentanyl or remifentanil), and neuromuscular relaxants (rocuronium, cisatracurium, or vecuronium). For maintenance of anesthesia, propofol infusion or inhalation anesthetics (sevoflurane or desflurane) are used. From the start of anesthesia induction to 15 minutes after, arterial blood pressure is monitored at 1-min interval using oscillometric method. The display of continuous arterial pressure on the anesthesia monitor is turned off during the 15-min study period. |
Active Comparator: arterial catheterization method
Continuous blood pressure monitoring through arterial catheter during induction of anesthesia
|
During the same time window for 1-min interval oscillometric method, arterial blood pressure is monitored using continuous blood pressure monitoring.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MAP integral
Time Frame: From the start of anesthesia induction to 15 minutes after
|
The area under the mean arterial pressure (MAP) of 65 mmHg calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area under MAP of 60, 50, 40 mmHg (mmHg∙min)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Duration of MAP <65, <60, <50, <40 mmHg (min)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Exposure to MAP <65, <60, <50, and <40 mmHg (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Exposure to continuous MAP <65, <60, <50, <40 mmHg for 1 minute or longer (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Area above MBP of 100, 110, 120, 140 mmHg (mmHg∙min)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
MAP standard deviation (mmHg)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
calculated using the MAP recorded every second
|
From the start of anesthesia induction to 15 minutes after
|
Use of vasopressor (binary)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
ephedrine, phenylephrine, norepinephrine (binary)
|
From the start of anesthesia induction to 15 minutes after
|
Use of vasopressor (dose)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
ephedrine (mg), phenylephrine (μg/kg), norepinephrine (μg/kg)
|
From the start of anesthesia induction to 15 minutes after
|
Crystalloid (ml)
Time Frame: From the start of anesthesia induction to 15 minutes after
|
Total amount of crystalloid administered
|
From the start of anesthesia induction to 15 minutes after
|
Collaborators and Investigators
Investigators
- Study Director: Karam Nam, MD, Seoul National University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SPROUT-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia, General
-
Universidad de AntioquiaCompletedAnesthesia, General | Anesthesia, IntravenousColombia
-
Children's Hospital of PhiladelphiaErasmus Medical Center; University of Texas Southwestern Medical Center; Children... and other collaboratorsCompletedPediatric Anesthesia | General Anesthesia | ElectroencephalographyUnited States, Australia, Switzerland, China, Netherlands
-
University Hospital, SaarlandCompletedGeneral Anesthesia | Regional Anesthesia | Immune FunctionGermany
-
Jagiellonian UniversityRecruitingAnesthesia, General | Analgesics, Opioid | Anesthesia, EndotrachealPoland
-
Antalya Training and Research HospitalCompletedAnesthesia, General | Anesthesia, Spinal | Umbilical CordTurkey
-
Tanta UniversityRecruitingSpinal Anesthesia | General Anesthesia | Inguinal Herniorrhaphy | NeonatesEgypt
-
Nordic Pharma SASCompletedSpinal Anesthesia | Outpatient Surgery | Short General AnesthesiaFrance
-
Samsung Medical CenterUnknownGeneral Anesthesia | Total Intravenous Anesthesia | Bispectral Index MonitoringKorea, Republic of
-
Armed Forces Hospital, PakistanCompletedGeneral Anesthesia | Epidural AnesthesiaPakistan
-
University of Wisconsin, MadisonCompletedGeneral Anesthesia | Intravenous AnesthesiaUnited States
Clinical Trials on 1-min interval oscillometric method
-
Rigshospitalet, DenmarkCompletedDiabetes Mellitus, Type 2Denmark
-
Medical University of WarsawCompletedAtrial Fibrillation Fluttering
-
Thomas RieglerUniversity of ZurichCompletedChronic Obstructive Pulmonary Disease | COPDSwitzerland
-
Ataturk UniversityRecruiting
-
Peking UniversityCompletedInflammation | Blood Pressure | Oxidative Stress | Lung FunctionChina
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingOvarian Cancer | Adnexal MassUnited States
-
American Academy of Family PhysiciansTerminatedOsteoarthritis | Gastroesophageal Reflux DiseaseUnited States
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance